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We have recently reported that chicken ovalbumin
upstream promoter transcription factor (COUP-TF) ac-
tivates human immunodeficiency virus type 1 (HIV-1)
gene transcription in glial and neuronal cells. Here, we
have examined the role of COUP-TF in microglial cells,
the major target cells for HIV-1 infection in brain. We
show that COUP-TF activates gene expression from both
the lymphotropic LAI and the macrophage-tropic JR-FL
HIV-1 strains. Although COUP-TF binds to the 2352/
2320 nuclear receptor responsive element of the long
terminal repeat, it functions as a transcriptional activa-
tor by acting on the 268/129 minimal promoter. This
region is a direct target of transcription factors Sp1 and
Sp3. We report the discovery and features of a physical
and functional interplay between COUP-TF and Sp1.
Our cotransfection experiments provide evidence for a
functional synergism between Sp1 and COUP-TF lead-
ing to enhanced transcriptional activity of the HIV-1
long terminal repeat through the Sp1 element. In con-
trast, Sp3 functions as a repressor of Sp1- or COUP-TF-
induced activation. We further demonstrate that
COUP-TF and Sp1 are capable of physically interacting,
via the DNA-binding domain of COUP-TF, in vitro and in
the cell. These findings reveal how the novel interplay of
Sp1 and COUP-TF families of transcription factors reg-
ulate HIV-1 gene expression.
Human immunodeficiency virus type 1 (HIV-1)1 infects the
central nervous system (CNS) and plays a direct role in the
pathogenesis of AIDS dementia (1, 2), but how the infection
leads to brain damage has been poorly understood. The CNS
resident macrophages or microglial cells (3) are the primary
target of HIV-1 infection in brain (4–7). Glial and neuronal
cells are capable of harboring a restricted infection with HIV-1
(8–10). HIV-1 infection is established in the CNS by viruses
present early in infection (11). Macrophage-tropic isolates in-
fect microglial cells more efficiently then do T cell tropic iso-
lates and predominate early in the infection (12). Therefore we
have performed our studies with the macrophage-tropic JR-FL
strain, compared with the T-tropic LAI strain.
HIV-1 gene expression is controlled by a combination of viral
and host cell transcription factors interacting with the long
terminal repeat (LTR) region (for review, see Refs. 13 and 14).
Recent studies have focused on transcription factors that reg-
ulate HIV-1 expression in brain cells. Analysis of HIV-1 di-
rected gene expression in transgenic mice derived from CNS-
isolated HIV-1 strains (15), suggests that HIV-1 replication in
the CNS uses transcription factors different from those in
non-neural tissues (16–18). Transcriptional activity of the
HIV-1 promoter is mediated by kB regulatory sequences of the
LTR, through the action of the transcription factor NF-kB, both
in neurons (19, 20) and in astrocytes (21). Besides the kB
regulatory element, our recent data have highlighted the im-
portance of the nuclear receptor-responsive element (NRRE),
which appears to be the point of convergence of a network of
physiological signals which modulate HIV-1 gene expression in
brain cells. We have described that the orphan nuclear recep-
tors COUP-TF/Ear3 (22–24) are present in three human brain
cell lines, oligodendroglioma TC-620, astrocytoma U373-MG,
and neuroblastoma SK-N-MC cells. Our data have also dem-
onstrated the importance of COUP-TF as a potent transcrip-
tional activator in oligodendroglioma cells, of both the lympho-
tropic LAI and the neurotropic JR-CSF HIV-1 LTR. They
revealed the action of the dopamine transduction pathway,
which coupled to COUP-TF, contributes to enhance HIV-1 gene
transcription in neuronal cells (25). Our findings have further
established the importance of the retinoic acid signaling path-
way in HIV-1 gene transcription in glial and neuronal cells
(26). Except for retinoid receptors, the role of transcription
factors belonging to the steroid/thyroid/retinoid receptor super-
family has not yet been described in microglial cells.
In this report, we have investigated the functional effect and
the molecular mechanisms by which the orphan nuclear recep-
tor COUP-TF regulates HIV-1 gene expression in a human
microglial cell line (27). Our findings reveal the importance of
COUP-TF as an activator of LTR-driven transcription of both
the T cell line-tropic LAI and the macrophage-tropic JR-FL
HIV-1 strains. We provide evidence for a novel physiological
and functional interaction between the DNA-binding domain of
COUP-TF and the transcription factor Sp1, leading to en-
hanced transactivation of the HIV-1 LTR. In addition, our data
reveal that the COUP-TF- and Sp1-induced stimulation is re-
pressed by the transcription factor Sp3. These data describe
novel molecular mechanisms which govern the network of in-
teractions between the HIV-1 LTR, the transcriptional activa-
tors COUP-TF and Sp1, and the repressor Sp3, in the regula-
tion of HIV-1 gene expression.
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MATERIALS AND METHODS
Plasmids Constructs—The LTR(JR-FL)-CAT and LTR(LAI)-CAT
vectors were described previously (25, 26, 28). The 268/180 and 240/
180 LTR-CAT vectors were constructed by subcloning into the SmaI
site of pUC19-CAT0 the HaeIII-HindIII and DdeI-HindIII blunt-ended
LTR insert, respectively, isolated from 2489/180 LTR(LAI)-CAT.
To construct the GST-COUP-1 vector, the plasmid RSV-COUP-TF
(gift of Dr. M. J. Tsai, Houston, TX) was digested with SmaI and EcoRI
and the COUP-TF insert was subcloned in-frame with the GST-encod-
ing sequences into the SmaI and EcoRI sites of pGEX2T. To construct
GST-COUP-2 and GST-COUP-3, the SmaI-SalI and SmaI-XmnI
COUP-TF fragments were isolated from the RSV-COUP vector, blunt-
ended, and inserted into the SmaI site of pGEX2T. The Sp1 cDNA was
excised with XbaI and EcoRI from the pEVR2-Sp1 vector (gift of Dr. G.
Suske, Marburg, Germany) and religated into the XbaI and EcoRI sites
of pBluescript KS2. To construct pRSV-COUP-TF, COUPdel308, and
COUPdel148, the EcoRI-EcoRI, EcoRI-SalI, and EcoRI-XmnI frag-
ments were isolated from RSV-COUP-TF, blunt-ended, and inserted in
the blunt-ended NotI site of pRc/RSV (Invitrogen).
Cell Culture, Transfections, and CAT Assays—Human microglial
cells (27) were grown in Dulbecco’s modified Eagle’s medium supple-
mented with 10% fetal calf serum and 10 mM HEPES in the presence of
penicillin-streptomycin (100 units/ml). Cells (106) were transfected by
the calcium phosphate precipitation method as described previously
(29) with either 1 pmol of plasmid reporter DNA or cotransfected with
reporter DNA (1 pmol) and the indicated expression vector: RSV-
COUP-TF (0.2 pmol; gift of Dr. M. J. Tsai; Houston, TX), CMV-Sp1 (0.2
or 0.5 pmol as indicated; gift of Dr. R. Tjian, Berkeley, CA), pRc/CMV-
Sp3 (0.2 or 0.5 pmol as indicated; gift of Dr. G. Suske, Marburg,
Germany). Each transfection was done in duplicate and repeated a
minimum of three separate times with at least two different plasmid
preparations. Cell extracts were prepared 48 h after transfection. CAT
assays were performed as described previously (29). Reaction mixtures
containing 15 mg of protein were incubated at 37 °C for 2 h.
Electrophoretic Mobility Shift Assays—EMSAs were performed with
nuclear proteins as described previously (25). Pure Sp1 protein (2
footprint units, Promega) was used in the presence of 3 mg of bovine
serum albumin. Mixtures were incubated for 15 min at 4 °C and pro-
tein-DNA complexes were analyzed by electrophoresis on a 4 or 6%
polyacrylamide gel in 0.25 3 TBE. For supershift assays, antibodies
directed against COUP-TF (gift of Dr. M. J. Tsai) or against Sp1 or Sp3
(Santa Cruz Biotechnology) or against T3R (gift of Dr. P. Chambon,
Strasbourg, France) or normal rabbit serum, were mixed with nuclear
proteins for 4 h at 4 °C prior addition of the probe.
Glutathione S-Transferase Fusion Protein Interaction Assay—GST
and GST fusion proteins were expressed in Escherichia coli BL-
21(DE3). Overnight cultures of bacteria that were newly transformed
with the plasmids were diluted with 20 volumes of medium, cultured for
several hours to an optical density at 600 nm of 0.6, and induced with
0.4 mM isopropyl b-D-thiogalactopyranoside at 37 °C for 3 h. Bacteria
from 125 ml of culture were harvested and resuspended in 1.5 ml of
NETN (20 mM Tris pH 8, 100 mM NaCl, 1 mM EDTA, 0.5% Nonidet P-40,
10 mg of leupeptin/ml, 10 mg of pepstatin/ml, 10 mg of aprotinin/ml, 1 mM
phenylmethylsulfonyl fluoride). The lysates were sonicated and after
centrifugation, the supernatants were mixed with glutathione-Sepha-
rose 4B beads (40 ml, Pharmacia) at 4 °C overnight in NETN buffer. The
35S-labeled input Sp1 protein was prepared by in vitro translation using
the TNT T7 system (Promega) according to the manufacturer’s sugges-
tions. The coated beads (40 ml) were washed with NETN and further
incubated for 2 h at 4 °C with 15 ml of the total in vitro translated
protein reaction mixture in a final volume of 300 ml of binding buffer (50
mM Tris-Cl, pH 7.6, 50 mM NaCl, 0.02% Tween 20, 0.02% bovine serum
albumin) containing antiproteases as in NETN. After extensive wash-
ing with washing buffer (50 mM Tris-Cl, pH 7.6, 150 mM NaCl, 0.02%
Tween 20) containing the antiproteases, the bound proteins were dis-
sociated by boiling for 5 min in Laemmli sample buffer and subjected to
SDS-PAGE.
Association of Proteins in Vitro—GST and GST fusion proteins were
expressed from a 2-ml bacterial culture and mixed with glutathione-
Sepharose 4B beads (Pharmacia) at 4 °C overnight in NETN buffer. The
coated beads (30 ml) were washed with NETN and further incubated for
2 h at 4 °C with pure Sp1 (2 footprint units, Promega) in 300 ml of
binding buffer. After extensive washing with washing buffer, the bound
proteins were dissociated with 20 mM glutathione, 50 mM Tris, pH 8
(15 ml), and subjected to EMSA in the presence of labeled Sp1
oligonucleotide.
Immunoprecipitations—Protein extracts were prepared according to
two distinct methods: cell lysates were prepared from cells plated in a
10-cm dish according to the reported procedure (30) or nuclear proteins
were isolated as described previously (25). Cell lysates or nuclear pro-
teins were resuspended in 400 ml of TNE (50 mM Tris, pH 8.0, 1%
Nonidet, 2 mM EDTA, and a mixture of protease inhibitors), mixed with
protein A-agarose beads (20 ml) and gently shaken for 1 h at 4 °C. The
suspension was briefly centrifuged and the supernatant was mixed with
3 ml of anti-Sp1 antibodies or preimmune serum. After overnight incu-
bation at 4 °C, protein A-agarose (30 ml) was added and mixed for 2 h.
After extensive washing of the beads with TNE, 15 ml of beads were
mixed with 5 ml of buffer Z (20 mM HEPES, pH 7.9, 1 mM MgCl2, 60 mM
KCl, 0.5 mM EDTA, 1 mM dithiothreitol, 10% glycerol) and either
subjected to EMSA in the presence of the 3L oligonucleotide probe, or
processed for Western blotting with COUP-TF antibodies, as described
previously (25).
RESULTS
COUP-TF Present in Microglial Cells Binds to the Nuclear
Receptor Responsive Element of the LTR of HIV-1 LAI and Not
HIV-1 JR-FL—We have previously shown that within different
brain cell lines (oligodendroglioma, astrocytoma, and neuro-
blastoma) COUP-TFs are the major protein species which in-
teract with the NRRE located in the 2352/2320 modulatory
region of the LTR (25) (Fig. 1). To examine whether COUP-TFs
are also present in human microglial cells and interact with the
NRRE, gel mobility supershift assays were performed with
nuclear proteins isolated from microglial cells, in the presence
of COUP-TF antibodies. With the 3L oligonucleotide probe,
corresponding to the NRRE sequence present in the lympho-
tropic HIV-1 LAI isolate, the results show that the COUP-TFs
FIG. 2. COUP-TF binding activity to the 2352/2324 LTR site of
HIV-1 in human microglial cells. Nuclear protein extracts (5 mg)
were assayed by gel retardation assay with 1 ng of 32P-end-labeled 3L
or 3N oligonucleotide probe. The DNA-protein complexes C1, C3, C39,
C4 are named as described previously (26). For supershift assays, 1 ml
of COUP-TF antiserum (lane COUP) or nonimmune serum (lane NIS)
was mixed with nuclear proteins 4 h prior addition of the 3L probe. The
sequence of the 3L and 3N synthetic oligonucleotides is indicated. Open
squares correspond to a mutant nucleotide.
FIG. 1. The HIV-1 LTR and localization of some binding sites.
NRRE, NF-kB, Sp1, and TATA elements are indicated.
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species do form the majority of the DNA-protein complexes C1,
C3, and C39 (Fig. 2, lanes 3–5). This confirms that within
human microglial cells, like in other brain cells, COUP-TFs are
the major nuclear proteins interacting with the NRRE. When
we used as a probe oligonucleotide 3N corresponding to the
NRRE site present in the LTR of the CNS-derived macrophage-
tropic HIV-1 JR-FL, the formation of complexes C1, C3, and
C39 was prevented (lane 2). This clearly indicates that COUP-
TFs present in nuclear extracts are unable to interact with the
mutant NRRE sequence present in the JR-FL LTR.
COUP-TF Stimulates LTR-directed HIV-1 Gene Transcrip-
tion in Microglial Cells via the Proximal LTR Region—To ex-
amine the role of COUP-TF on HIV-1 gene transcription in
microglial cells, transfection experiments were performed with
a LTR-CAT reporter vector, containing the CAT gene under the
control of the HIV-1 LTR region. With construct 1 containing
the LTR of the HIV-1 LAI strain (Fig. 3), COUP-TF acts as a
transcriptional activator of the HIV-1 genome, since in trans-
fection experiments, LTR-driven CAT expression was stimu-
lated 4.8-fold. It was interesting to compare this result with
that of construct 2 containing the LTR region from the HIV-1
JR-FL, since as shown above (Fig. 2), the NRRE site of the
JR-FL LTR contains mutations which prevent the binding of
COUP-TF. Surprisingly, CAT expression was still stimulated
3.8-fold, indicating that the mutation of the NRRE does not
prevent COUP-TF-induced activation.
The LTR sequences responsible for the COUP-TF-induced
activation were delineated by transfecting a series of LTR-CAT
vectors containing 59-deletions of the LTR region (Fig. 3). Al-
though the basal level of transcription dropped to 10% with
289/180 LTR-CAT and 268/180 LTR-CAT, compared with
the full-length vector, COUP-TF was still able to exert a re-
spective 6.1- and 6.8-fold transcriptional stimulation. The
COUP-TF-induced activation was abolished only by the re-
moval of the two binding sites of the Sp1 transcription factor
between position 268 and 240. Moreover, the 268/129 LTR
region was still able to mediate a 5.6-fold COUP-TF-induced
stimulation, allowing us to localize the COUP-TF response
element within the minimal 268/129 region. This result indi-
cates that the action of COUP-TF on the LTR is not mediated
via the NRRE site, but rather via the minimal 268/129 LTR
site. It further suggests that COUP-TF needs the presence of
the two Sp1 elements located within the 268/240 region and is
unable to function via interactions with the TATA element
alone.
To test whether COUP-TF could activate any promoter com-
posed of Sp1 sites and a TATA element, we performed trans-
fection experiments with the pUC-CAT2 vector, containing the
simian virus 40 (SV40) early promoter formed by six Sp1 sites
and a TATA box. In microglial cells, COUP-TF activated the
SV40 promoter only 2-fold. In contrast, in HeLa cells,
COUP-TF was able to stimulate transcription about 10-fold
(results not shown). These findings suggest that the action of
COUP-TF, via Sp1 sites, is dependent both on the promoter
context and the cell type.
COUP-TF Does Not Bind Directly to the T3R Element of the
HIV-1 LTR—It has been reported that the thyroid hormone
receptor T3R, another member of the nuclear receptor super-
family interacts directly with the T3R element (T3RE) overlap-
ping the Sp1 sites within the 274/250 HIV-1 LTR (31). There-
fore the possibility existed that COUP-TF might also bind
directly to this region. To test this hypothesis, we carried out
gel retardation experiments, using as a probe oligonucleotide
T3RE containing the three Sp1-binding sites (Fig. 4A). With
nuclear proteins isolated from microglial cells, four DNA-pro-
FIG. 3. Functional effects of
COUP-TF on HIV-1 LTR-driven tran-
scription in human microglial cells.
Left panel, LTR-CAT constructs used in
transient expression assays. The LTR re-
gion of the LAI and JR-FL HIV-1 strains
was 59-end deleted. Right panel, relative
CAT activities in microglial cells trans-
fected with the LTR-CAT constructs, ei-
ther alone or in the presence of the
COUP-TF expression vector. CAT activi-
ties are expressed relative to that of con-
struct 1 taken as 1. Numbers in brackets
indicate the fold stimulation induced by
COUP-TF.
FIG. 4. Sp1 and Sp3 present in human microglial cells interact
with the 283/245 region of the HIV-1 LTR. A, gel retardation
assays with the T3RE oligonucleotide probe and 10 mg of nuclear
extracts from microglial cells. Competition assays were performed with
a 50-fold molar excess of unlabeled T3RE or 3L oligonucleotide. Super-
shift assays were carried out with antibodies directed against proteins
indicated on top or with nonimmune serum (NIS). The sequence of the
T3RE oligonucleotide and the three Sp1 sites are indicated. B, immu-
noblot detection of Sp1 and Sp3 in microglial cells. Nuclear proteins (10
mg) from microglial cells were fractionated on a SDS-polyacrylamide
gel, blotted on nitrocellulose filter, and incubated with antibodies di-
rected against Sp1 (lane 1) or Sp3 (lane 2).
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tein complexes a to d were detected. The formation of com-
plexes a to c was abolished with a 50-fold molar excess of
homologous oligonucleotide T3RE, showing the specificity of
these interactions (lanes 1 and 2). The minor complex d ap-
peared less specific. In contrast, oligonucleotide 3L which binds
COUP-TF, failed to compete for the formation of all four com-
plexes (lane 3). This result already indicates that COUP-TF is
not present within the complexes formed with the T3RE
sequence.
To identify the nature of the T3RE-binding proteins present
in microglial cells, supershift assays were performed with an-
tibodies directed against transcription factors previously de-
scribed to bind to this site. As expected, antibodies directed
against Sp1 were able to supershift complex b (Fig. 4, lanes 6).
Antibodies directed against Sp3 were able to prevent the for-
mation of complexes a and c (lane 4), and a mixture of both
anti-Sp1 and anti-Sp3 antibodies prevented the formation of
complexes a, b, and c (lane 5). These results clearly show that
only Sp1 and Sp3 proteins present in microglial cells interact
directly with the T3RE sequence. Surprisingly antibodies di-
rected against the thyroid hormone receptor T3R did not alter
the pattern of the complexes (lane 7), suggesting that either
T3R is not expressed in microglial cells or has a lower binding
affinity compared with Sp1 and Sp3. As a control, the com-
plexes were unaffected in the presence of nonimmune serum
(lane 8). A closely related pattern was already described with
proteins from CV1, HeLa, and Jurkat cells (32, 33). The gen-
eration of the two a and c Sp3-specific complexes coincides with
the appearance of at least two bands in the 80- and 55-kDa
range in Western blots with anti-Sp3 antibodies (Fig. 4B).
Regulation of HIV-1 LAI and JR-FL LTR-directed Gene
Transcription by COUP-TF, Sp1, and Sp3—Since COUP-TF
stimulates transcriptional activity of the LTR 4–5-fold, by act-
ing on the same response element as Sp1 and Sp3, we investi-
gated how HIV-1 gene transcription is modulated by the indi-
vidual action of each factor as well as by the combination of the
various transcription factors (Fig. 5). Cotransfection experi-
ments with the LTR(JR-FL)-CAT vector showed that overex-
pression of Sp1 resulted in a 4-fold transcriptional stimulation.
Interestingly, overexpression of both COUP-TF (0.2 pmol) and
Sp1 (0.5 pmol) led to a 13-fold increase in CAT activity. This
indicates that both proteins are able to function in a synergistic
manner. Sp3 has been described as a bifunctional transcription
regulator of eukaryotic gene expression (34) and as a repressor
of HIV-1 gene transcription in HeLa and Drosophila cells (32).
In microglial cells, Sp3 functions also as a potent repressor of
LTR-directed HIV-1 gene transcription, since the remaining
CAT activity was 30% with 0.2 or 0.5 pmol of expression vector.
Moreover overexpression of Sp3 resulted in a 2-fold inhibition
of both the Sp1- or COUP-TF-mediated stimulation (Fig. 5).
It was of interest to examine the effect of the activators
COUP-TF and Sp1 on the transcriptional activity mediated by
the 268/180 proximal LTR region. In this region, the LTR
sequence of the LAI and JR-FL isolates are similar. Interest-
ingly, the proximal promoter mediated a 6.0-fold COUP-TF-
induced stimulation, compared with the lower 3.8-fold stimu-
lation mediated by the entire LTR region. Similarly, Sp1
transactivated the proximal promoter 4.2- and 14-fold, after
transfection of 0.2 and 0.5 pmol of Sp1 vector, respectively.
Moreover, the combined action of COUP-TF (0.2 pmol) and Sp1
(0.2 or 0.5 pmol) resulted in a synergistic effect, since transcrip-
tion was stimulated 15- and 27-fold, respectively.
The COUP-TF protein can be divided into distinct functional
domains, such as a N-terminal DNA-binding domain and a
C-terminal dimerization domain. To identify which part of the
COUP-TF protein is involved in transactivation, we cotrans-
fected LTR(JR-FL)-CAT with vectors expressing 39-deletion
mutants of COUP-TF (Fig. 6). Results demonstrate that the
C-terminal region is required for transactivation; construct
pRSV-COUPdel148 containing only the DNA-binding domain
was unable to significantly activate the HIV-1 promoter.
COUP-TF and Sp1 Are Able to Interact in Vitro and in the
Cell—To decipher the mechanism whereby COUP-TF and Sp1
mediate a transcriptional synergistic activation, we first tested
whether COUP-TF and Sp1 interact in vitro. We generated a
GST-COUP fusion protein (Fig. 7A) and analyzed the ability of
in vitro translated Sp1 in the presence of [35S]methionine to
interact with GST-COUP-1. SDS-PAGE analysis of proteins
retained by glutathionine-Sepharose shows that 35S-labeled
Sp1 associates with GST-COUP-1 (Fig. 7B, lane 4). This asso-
ciation is specific, since Sp1 was bound to GST-COUP-1 but not
to GST alone (lane 3). Three labeled bands are detected on
SDS-PAGE, which correspond to the three bands of approxi-
mately 100, 55, and 40 kDa, detected with the input protein on
Western blots (lane 1).
To localize the domain of COUP-TF that mediates interac-
tion with Sp1, we constructed GST-COUP expression vectors
containing serial 39 deletions of COUP-TF (Fig. 7A). Results
from GST pull down experiments show that GST-COUP-2 and
even GST-COUP-3 encoding residues 49 to 148 of COUP-TF
were still able to mediate association with Sp1 (lanes 5 and 6),
confirming that the N-terminal part of COUP-TF containing
the DNA-binding domain is sufficient for interaction with Sp1
in vitro.
FIG. 5. Regulation of HIV-1 gene transcription by COUP-TF,
Sp1, and Sp3 in human microglial cells. Transient expression ex-
periments were performed by cotransfecting the HIV-1(JR-FL)-CAT or
268/180 LTR-CAT reporter vectors (1 pmol) with vectors expressing
COUP-TF (0.2 pmol), Sp1 (0.5 pmol), or Sp3 (0.5 pmol) as indicated.
Histograms show the CAT activities expressed relative to the value
obtained with the LTR-CAT reporter vector. Values correspond to an
average of at least three independent experiments done in duplicate.
The standard deviation did not exceed 20%.
FIG. 6. Transcriptional activity of COUP-TF deletion mutants.
Microglial cells were co-transfected with LTR(JR-FL)-CAT and vectors
expressing deletion mutants of COUP-TF. Cell extracts were prepared
48 h after transfection and CAT activities were determined. Activities
are expressed as fold stimulation over the activity of LTR-CAT cotrans-
fected with the parental pRc/RSV vector.
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We further investigated the interactions between COUP-TF,
Sp1, and the Sp1 DNA-binding site. Pure Sp1 protein was
incubated with glutathione-Sepharose beads retaining bacteri-
ally expressed GST-COUP protein. After extensive washings,
the bound proteins were eluted and analyzed by gel shift assays
with the Sp1 oligonucleotide probe (Fig. 7C). Addition of pure
Sp1 protein in the binding reaction led to the formation of a
retarded complex (lane 1). As expected GST-COUP fusion pro-
teins alone were unable to bind to the Sp1 probe (lanes 6–8).
Interestingly, addition in the binding reaction of GST-COUP-1
preincubated with Sp1 resulted in a supershift of the Sp1-DNA
complex (lane 2). This result demonstrates that COUP-TF is
able to physically associate with Sp1 bound to its DNA-binding
site. Both truncated GST-COUP-2 and GST-COUP-3 proteins
were still able to supershift the Sp1-DNA complex (lanes 3 and
4), indicating that the N-terminal sequences containing the
DNA-binding domain of COUP-TF are sufficient for binding
with Sp1. As a control, a barely detectable band was formed
when Sp1 was incubated with GST (lane 5), showing the spec-
ificity of the interaction between GST-COUP and Sp1.
These in vitro results were confirmed in vivo by immunopre-
cipitation experiments with extracts from microglial cells (Fig.
8). The presence of COUP-TFs species was detected in gel shift
assays with the 3L probe (Fig. 8A). Antibodies directed against
Sp1 (lanes 4 and 7), but not non-immune serum (lane 6), were
able to immunoprecipitate endogeneous COUP-TF species. As
FIG. 7. The DNA-binding domain of COUP-TF interacts with
Sp1 in vitro. A, schematic representation of GST-COUP-TF constructs.
Plasmids expressing deletion mutants of COUP-TF were constructed as
described under “Materials and Methods.” B, visualization of the inter-
action between COUP-TF and Sp1. The Sp1 protein was translated in
wheat germ lysates (Promega) and analyzed by Western blot with
anti-Sp1 antibodies (lane 1). 35S-Labeled Sp1 protein (lane 2) translated
in wheat germ lysate, was incubated with bacterially expressed GST or
GST-COUP (constructs 1 to 3) immobilized on glutathione-Sepharose
beads. After extensive washing, the bound proteins were eluted and
analyzed by SDS-PAGE followed by autoradiography (lanes 3–6). C,
analysis of association of Sp1 with GST-COUP-TF by gel mobility shift
assays. Sp1 protein (2 footprint units, Promega) was incubated with
bacterially expressed GST or GST-COUP-1, -2, -3 proteins immobilized
on glutathione-Sepharose beads. After extensive washing, the bound
proteins were eluted and analyzed by gel mobility shift assays. Binding
assays were performed with 1 ng of labeled Sp1 probe either with Sp1
protein (2 footprint units, Promega, lane 1) or with bacterially ex-
pressed GST or GST-COUP fusion proteins incubated in the presence
(lanes 2–5) or absence of Sp1 (lanes 6–8), as described under “Materials
and Methods.” DNA-protein complexes were separated on a 4% poly-
acrylamide gel.
FIG. 8. Association of COUP-TF and Sp1 in vivo. A, cell lysates
(lanes 1–6) or nuclear protein extracts (lanes 7 and 8) were prepared
and immunoprecipitated in the presence of anti-Sp1 antibodies or non-
immune serum (NIS). Immunoprecipitates were assayed for the pres-
ence of COUP-TFs by EMSA performed with the labeled 3L probe, in
the absence or presence of an excess of unlabeled 3L competitor, or in
the presence of COUP-TF antibodies (lane 8). As a control, EMSA was
performed on cell lysates not subjected to immunoprecipitation (lanes 1
and 2). B, the ability of anti-Sp1 to coimmunoprecipitate COUP-TF was
visualized by Western blotting with COUP-TF antibodies (lane 2). As a
control, lane 1 corresponds to nonimmunoprecipitated nuclear proteins.
The arrow points to the 45-kDa COUP-TF protein.
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a control, in the absence of antiserum, no complex was detected
(lane 3). The amount of immunoprecipitated proteins was de-
pendent on the method used for protein extraction, as described
under “Materials and Methods”: when we subjected cell lysates
to immunoprecipitation, complex C1 was predominant (lane 4);
when we used nuclear protein extracts, complexes C1, C3, C39,
and C4 were detected (lane 7). As expected, complexes C1, C3,
and C39 were specifically competed with an excess of 3L com-
petitor (lane 5) and their formation was prevented in the pres-
ence of COUP-TF antibodies (lane 8). Surprisingly, protein
forming complex C4 was also partially immunoprecipitated,
with anti-Sp1, but not with nonimmune serum, which may
suggest an interaction of this protein with either Sp1 or COUP-
TF. In addition, the ability of anti-Sp1 antibodies to coimmu-
noprecipitate the COUP-TF protein was visualized by Western
blotting with COUP-TF antibodies (Fig. 8B).
DISCUSSION
In this report we have investigated the regulation of HIV-1
gene transcription in human microglial cells, which represent
the primary target of HIV-1 infection in the central nervous
system. Since we have previously shown that the orphan nu-
clear receptor COUP-TF is expressed in brain cells and leads to
a transcriptional stimulation of the HIV-1 genome in oligoden-
droglioma and neuronal cells (25), we have focused our studies
on the regulation of HIV-1 gene transcription by COUP-TF in
microglial cells. It is now well established that COUP-TF is
able to exert both positive and negative effects on gene expres-
sion, depending upon the promoter and the cell contexts (29,
35–38). We show here that COUP-TF proteins are present in
human microglial cells and interact directly with the NRRE,
spanning the 2356/2320 LTR region of the lymphotropic
HIV-1 LAI isolate, but are unable to bind to the mutant NRRE
present in the macrophage-tropic HIV-1 JR-FL isolate. Inter-
estingly, our transient expression data reveal that COUP-TF/
Ear3 is able to activate HIV-1 LTR-driven transcription in
microglial cells, independently of the NRRE sequence. This
shows that COUP-TF is able to transactivate the LTR from the
lymphotropic LAI and the macrophage-tropic JR-FL isolates.
We have already reported that distinct cell-type specific and
sequence-dependent mechanisms govern COUP-TF-induced
stimulation. In oligodendrocytes this transcription factor stim-
ulates HIV-1 gene transcription, either by direct interactions
with its NRRE target site or also, depending on the LTR se-
quence, by cross-coupling interactions with downstream-lo-
cated proteins. In neuronal SK-N-MC cells, the transcriptional
stimulation induced by COUP-TF in the presence of dopamine
is mediated by the minimal 268/129 LTR region (25). Simi-
larly the NRRE site in the JR-CSF LTR is not indispensable for
the stimulation induced by the retinoic acid receptor, since the
retinoid action appears to be mediated by downstream-located
elements, such as the 2247/2222 AP-1 region and, to a lesser
extent, the NF-kB region (26).
We show here that the minimal 268/129 LTR region, con-
taining two Sp1-binding sites, is sufficient for COUP-TF-medi-
ated stimulation. Our cotransfection and in vitro experiments
demonstrate the ability of COUP-TF to transactivate the LTR
indirectly via the Sp1 sites, by direct interaction with the Sp1
protein. We present evidence for a direct association between
the N-terminal part of COUP-TF, containing the DNA-binding
domain, with Sp1. Our data show that COUP-TF can interact
with Sp1 both in vitro and in microglial cells. This association
leads to a functional cooperation between the two proteins,
which is detected with the full-length LTR as well as the
268/180 LTR region. Moreover we show that the C-terminal
domain of COUP-TF is involved in the transcriptional
activation.
Previous studies have already described that the action of
COUP-TFs can be mediated not only by direct interaction with
their DNA-binding site, but also by protein-protein interaction.
COUP-TFI/Ear3 and ARP-1/COUP-TFII are able to directly
target components of the basal transcription machinery, such
as the basal transcription factor TFIIB (39, 40). TFIIB recog-
nizes and associates with COUP-TF and two other members of
the steroid hormone receptor family, via their activation do-
main (39). In contrast, our findings reveal that COUP-TF as-
sociates with Sp1 via its N-terminal part, containing the DNA-
binding domain. A direct interaction between COUP-TF and
the transcription factors Oct1 and Oct2 has also been demon-
strated in the regulation of the vHNFI promoter (30).
It has been well established that the Sp1 transcription factor
(41) plays an essential role in the regulation of basal transcrip-
tion as well as in Tat-mediated transactivation of the HIV-1
LTR (42–44). Recent reports describe that Sp1 is critical for in
vivo transcriptional regulation of HIV, through its interaction
with other DNA-binding proteins. A cooperative interaction
between Sp1 and NF-kB, bound to the two adjacent binding
sites, is required for optimal HIV-1 enhancer activation and
inducible HIV-1 gene expression (32, 45, 46). A physical inter-
action between Sp1 and the p53 tumor-suppressor gene has
been described in the tumor necrosis factor-induced transcrip-
tional activation of the HIV-1 LTR (47). Moreover in vitro and
in vivo data suggest a direct interaction between Sp1 and Tat
during transactivation (48, 49).
Here our findings reveal a novel direct association between
two zinc finger proteins, Sp1 and COUP-TF, which leads to
enhanced transcriptional activation of the HIV-1 genome.
These data suggest a more general model for gene activation by
the orphan receptor COUP-TF or steroid/thyroid/retinoid re-
ceptors, in the presence of Sp1-binding sites. As shown here,
Sp1 bound to its DNA-binding site is able to associate directly
with the N-terminal DNA-binding domain of the nuclear recep-
tor. It is well known that the adjacent TATA element binds the
general transcription factor TFIID, which directly interacts
with TFIIB, which itself is able to bind COUP-TF. In such a
situation, the nuclear receptor may function as an adaptor
protein, bringing together Sp1 and TFIIB, thereby enhancing
communication between the general transcription machinery
and Sp1. Alternatively, COUP-TF may bring together Sp1 and
a cell type-specific nuclear factor, leading to various levels of
activation induced by COUP-TF in different cell types. The
precise mechanisms which account for our observations in the
case of HIV-1 and SV40 gene transcription need to be further
investigated.
The Sp1 multigene family contains three closely related
members Sp1, Sp3, and Sp4 which recognize the GC box and
the GT motif (33). While Sp1 and Sp4 function as transcrip-
tional activators, Sp3 is a bifunctional transcription regulator,
whose activity is dependent upon the promoter and the cellular
contexts (33, 34). Recent reports have established that different
members of the Sp1 family exert opposite transcriptional reg-
ulation of the HIV LTR. While Sp1 and Sp4 stimulate tran-
scription of the LTR, Sp3 markedly represses the HIV promoter
activity in HeLa and Drosophila SL2 cells. Sp3-dependent re-
pression is dependent on the presence of the DNA-binding
domain, indicating that repression occurs through interference
with Sp1 binding to the GC motifs (32). Our data confirm that
Sp1 and Sp3 are present in microglial cells, and exert an
antagonist action on LTR-driven transcription. Moreover they
show that Sp3 is able to mediate transcriptional repression not
only of the Sp1 action, but also of the COUP-TF action exerted
via Sp1.
Only a limited number of studies have been devoted to HIV-1
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gene transcription in macrophages and microglial cells. A dif-
ferential role of LTR elements for the regulation of basal and
Tat-mediated transcription of HIV-1 has been reported in stim-
ulated and unstimulated primary human macrophages (50).
Our findings establish the essential role of the orphan nuclear
receptor COUP-TF as a transcriptional activator of LTR-di-
rected HIV-1 gene expression in microglial cells. They further
reveal a novel mechanism of HIV-1 gene transactivation by
direct association of COUP-TF with Sp1, thus enhancing tran-
scription via the minimal LTR region. Our present and previ-
ous studies (25) reveal the remarkable diverse mechanisms by
which COUP-TF regulates gene transcription of distinct HIV-1
strains and in different brain cells.
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